Intravascular Stents Market To Reach $22.69 Billion By 2030

Intravascular Stents Market Growth & Trends

The global intravascular stents market size is expected to reach USD 22.69 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 8.0% from 2023 to 2030. The growth of the market can be attributed to the increasing prevalence of peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). According to the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) accounted for approximately 19.05 million deaths worldwide.

Additionally, cerebrovascular diseases were responsible for approximately 7.08 million deaths globally during the same year. These alarming statistics underscore the significant burden of cardiac diseases and emphasize the urgent need for effective interventions, such as intravascular stents. The demand for these medical devices is driven by the necessity to address the rising incidence of PVDs and CAD and to provide patients with enhanced treatment options for better cardiovascular outcomes. As a result, intravascular stents play a critical role in managing and treating these prevalent cardiovascular conditions, contributing to the growth of the market.

The increasing prevalence of coronary artery diseases (CADs), which occur when plaque accumulates in the arteries, has led to a growing demand for percutaneous coronary intervention treatments involving stents. This surge in demand is expected to be the primary driver fueling the expansion of the coronary stent market. According to a report released in February 2022 by the Heart and Stroke Foundation of Canada, approximately 750,000 individuals in the country live with heart failure, and around 100,000 new cases are diagnosed annually.

By 2030, the healthcare costs associated with heart failure in Canada are projected to reach up to USD 2.8 billion annually. Consequently, the market for intravascular stents is anticipated to experience rapid growth throughout the forecast period due to the significant number of cardiac patients and the increasing economic burden caused by heart failure in the nation. Furthermore, the market is expected to be supported by the rising prevalence of CAD risk factors, including age, hypertension, diabetes, and others, during the projection period.

 Request a free sample copy or view report summary: Intravascular Stents Market Report

Intravascular Stents Market Segmentation

• The drug-eluting stents (DES) segment dominated the market in 2022, holding the largest share of 58.22%. DES has proven efficacy in reducing restenosis compared to bare metal stents (BMS) and offers a lower incidence of major adverse cardiac events (MACE)

• The balloon-expanding stents segment also held a significant share of 53.91% in the market in 2022. Balloon-expanding stents provide a notable advantage by enabling precise and controlled expansion within the affected blood vessel. The segment's growth is further fueled by the increasing preference for minimally invasive procedures

• In 2022, the coronary stents segment held the largest market share at 77.46%. The rising prevalence of coronary artery diseases (CADs) and the growing demand for percutaneous coronary intervention treatments are driving the expansion of this segment

•  In 2022, the hospital & cardiac centers segment dominated the market, representing the largest share of 74.55%. These specialized medical facilities play a crucial role in diagnosing and treating a wide range of cardiovascular diseases, including conditions related to peripheral arterial disease

• North America emerged as the leading market region in 2022, holding the largest share of 43.79%. The region's robust healthcare infrastructure, advanced medical facilities, and skilled healthcare professionals contribute to the easy accessibility of peripheral vascular stents for patients in the region

• Key market players include Boston Scientific Inc., Medtronic, Terumo Medical, Abbott, Biotronik, Lifetech, iVascular SLU, Stryker, Cook Medical, Microport Scientific Corporation, Stentys S.A., Hellman & Friedman (Cordis Inc.), B Braun Melsungen AG

Intravascular Stents Market Segmentation

Grand View Research has segmented the global intravascular stents market based on type, mode of delivery, product, end-use, and region:

Intravascular Stents Type Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Eluting Stents (DES)

• Bare Metal Stents (BMS)

• Bioabsorbable Stents

Intravascular Stents Mode of Delivery Outlook (Revenue, USD Million, 2018 - 2030)

• Self-expanding Stents

• Balloon-expandable Stents

Intravascular Stents Product Outlook (Revenue, USD Million, 2018 - 2030)

• Coronary Stents

• Peripheral Stents

  • Iliac Artery Stents

  • Femoral Artery Stents

  • Carotid Artery Stents

  • Renal Artery Stents

  • Other Peripheral Stents

• Neurovascular Stents

  • Intracranial Stents

  • Flow Diverters

Intravascular Stents End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Cardiac Centers

• Ambulatory Surgical Centers

• Others

Intravascular Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Denmark

• Sweden

• Norway

• Asia Pacific

• Japan

• China

• India

• South Korea

• Australia

• Thailand

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East & Africa

• South Africa

• Saudi Arabia

• UAE

• Kuwait

List of Key Players in the Intravascular Stents Market

• Boston Scientific Inc.                    

• Medtronic             

• Terumo Medical                

• Abbott       

• Biotronik               

• Lifetech                

• iVascular SLU                   

• Stryker                  

• Cook Medical                    

• Microport Scientific Corporation              

• Stentys S.A.                      

• Hellman & Friedman (Cordis Inc.)

• B Braun Melsungen AG